Neomycin overdosage: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) m (→Overdosage) |
Gerald Chi (talk | contribs) m (→Overdosage) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Overdosage== | ==Overdosage== | ||
Because of low absorption, it is unlikely that acute overdosage would occur with oral neomycin. However, prolonged administration could result in sufficient systemic drug levels to produce [[neurotoxicity]], ototoxicity, and/or nephrotoxicity. | Because of low absorption, it is unlikely that acute overdosage would occur with oral neomycin. However, prolonged administration could result in sufficient systemic drug levels to produce [[neurotoxicity]], [[ototoxicity]], and/or [[nephrotoxicity]]. | ||
[[Hemodialysis]] will remove neomycin from the blood.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NEO-FRADIN (NEOMYCIN SULFATE) SOLUTION [X-GEN PHARMACEUTICALS, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aea1d3e4-604a-4680-91e2-cce6a128a1b5 | publisher = | date = | accessdate = }}</ref> | [[Hemodialysis]] will remove neomycin from the blood.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NEO-FRADIN (NEOMYCIN SULFATE) SOLUTION [X-GEN PHARMACEUTICALS, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aea1d3e4-604a-4680-91e2-cce6a128a1b5 | publisher = | date = | accessdate = }}</ref> | ||
Latest revision as of 17:27, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overdosage
Because of low absorption, it is unlikely that acute overdosage would occur with oral neomycin. However, prolonged administration could result in sufficient systemic drug levels to produce neurotoxicity, ototoxicity, and/or nephrotoxicity.
Hemodialysis will remove neomycin from the blood.[1]
References
Adapted from the FDA Package Insert.